On-demand education
Prof. Cornford and Dr. Briers discuss the need for patient input in the EAU Guidelines
WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant? Novelties for the practicing urologist?
PARP Inhibitor in Prostate Cancer. Part III
New insights in treatment of bladder cancer: From localised to metastatic diseases
Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)
PARP inhibitors in prostate cancer. Part 2
Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments
Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice
Artificial intelligence: The role for research and patient treatment
Patient stratification and risk related treatment of NMIBC
UROwebinar: PARP inhibitors in prostate cancer. Part 1
Robotic Retzius sparing prostatectomy
Dr. Toine van der Heijden about the three different diversions mentioned in the EAU guidelines after cystectomy
Dr. Oscar Rodriguez Faba talks about how we can improve the organ pool for kidney transplantation
Identification and management of patients with nmCRPC
